ICMS Treatment Registry

The field cell based medicine is a rapidly expanding presence in the global medical community. The ICMS recognizes that with the growth in the number of clinics offering stem cell treatments around the world, the need for an independent registry to collect and evaluate patient data has never been greater. To answer this need, the ICMS has built a comprehensive Treatment Registry to provide long-term follow up for patient who have received cell based medical treatments.

Based upon the Guidelines for Re-Implantation of Adult Stem Cells, this unique Registry is a secure, HIPPA compliant, web-based data collection system that tracks outcomes and complications from cell based medical treatments.

Data within the registry is collected from patient surveys and interviews at set intervals of 3, 6, and 12 months, and 2, 3, 4, 5, 10 and 20 years after the treatment.

Participation in the ICMS Treatment Registry is reserved for those clinics that active in the ICMS Accreditation Program. By participating in the Registry, clinics share information on the collection, processing and implantation of the cells being used. All data collected in the registry is confidential and secure.

The data collected is entirely confidential. The clinic and physician's office maintains the communication with patients through the Treatment Registry, but patient data is never shared. The ICMS reviews outcomes data, and manages any occurance of patient-reported complications.